Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Jock Itch Butenafine Hydrochloride 10 mg/g Cream — NDC 51672-2101-1 (Billing 51672-2101-01)
by Sun Pharmaceutical Industries, Inc. · 1 TUBE in 1 CARTON / 15 g in 1 TUBE
This is a package of Jock Itch Butenafine Hydrochloride 10 mg/g Cream from Sun Pharmaceutical Industries, Inc., marketed since Nov 2017 and currently FDA-listed. It is the main listing for this product, which comes in 4 package sizes.
NDC 51672-2101-01
🏷️ FDA NDC (as labeled)
51672-2101-1
billing pads the package segment with a zero
This package
Contains15 g in 1 tube
Pack sizes4 compare ↓
Main listing for product 51672-2101 · Also comes in:
30 g 51672-2101-2
12 g 51672-2101-8
24 g 51672-2101-9
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
51672-2101-1
Product NDC
51672-2101
11-digit billing NDC
51672210101
RxCUI
1298448
UNII
R8XA2029ZI
Application #
ANDA205181
SPL Set ID
14a23a39-b567-4db4-bac0-c008c0ca6171
Established class (EPC)
Benzylamine Antifungal
Chemical class
Benzylamines
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2017-11-17
Route
TOPICAL
Dosage form
CREAM
Substance
BUTENAFINE HYDROCHLORIDE
Quick answers
- RxCUI (RxNorm): 1298448
Why two NDCs?
The FDA registers this code as 51672-2101-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 51672-2101-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Benzylamine Antifungal class.
Pharmacologic class
Benzylamine Antifungal
Drug family (ATC)
Other antifungals for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
📗 Our plain-language guide HelloPharmacist
- It treats fungal skin infections. Depending on the product, that means athlete's foot between the toes, jock itch and ringworm. It also relieves itching, burning, cracking and scal...
- Wash the area with soap and water and dry it completely. Then apply the cream as your product directs. Wash your hands afterward. Jock itch and ringworm are usually once a day for...
- On products labeled for athlete's foot, the directions are twice a day for 1 week or once a day for 4 weeks, or as your doctor directs. Wear well-fitting, ventilated shoes and chan...
- How long do I use it for athlete's foot?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
💬 Questions about Butenafine Hydrochloride?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 51672-2101-01 You're viewing this Main listing | 1 TUBE in 1 CARTON / 15 g in 1 TUBE | 2017-11-17 | — | Active |
| 51672-2101-02 51672-2101-2 | 1 TUBE in 1 CARTON / 30 g in 1 TUBE | 2017-11-17 | — | Active |
| 51672-2101-08 51672-2101-8 | 1 TUBE in 1 CARTON / 12 g in 1 TUBE | 2017-11-17 | — | Active |
| 51672-2101-09 51672-2101-9 | 1 TUBE in 1 CARTON / 24 g in 1 TUBE | 2017-11-17 | — | Active |
Pack size FAQ
What quantity is in this package?
This package is listed by the FDA — 1 tube in 1 carton / 15 g in 1 tube.
What NDC number is used to bill for this package of Jock Itch Butenafine Hydrochloride 10 mg/g Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Athletes Foot 10 mg/g 70677-1269-01 | STRATEGIC | 1 tube | $0.307 | — | Availability likely | — |
| Athletes Foot 10 mg/g 00363-2100-02 | Walgreen | 1 tube | — | — | FDA listed | — |
| Jock Itch 10 mg/g 00363-2101-08 | Walgreen | 1 tube | — | — | FDA listed | — |
| Lotrimin Ultra 1 g/100g 11523-0082-01 | Bayer | 1 tube | — | — | FDA listed | — |
| Lotrimin Ultra Ringworm 1 g/100g 11523-0158-02 | Bayer | 1 tube | — | — | FDA listed | — |
| Lotrimin Ultra Athletes Foot 1 g/100g 11523-4338-01 | Bayer | 1 tube | — | — | FDA listed | — |
| Lotrimin Ultra Jock Itch 1 g/100g 11523-4339-01 | Bayer | 1 tube | — | — | FDA listed | — |
| Athletes Foot 10 mg/g 11673-0016-02 | Target | 1 tube | — | — | FDA listed | — |
| Jock Itch Cream 10 mg/g 11673-0436-01 | TARGET | 1 tube | — | — | FDA listed | — |
| Athletes Foot 10 mg/g 11822-2100-02 | Rite | 1 tube | — | — | FDA listed | — |
| Butenafine Hydrochloride 10 mg/g 21130-0965-01 | Albertsons | 1 tube | — | — | FDA listed | — |
| Butenafine Hydrochloride Athletes Foot 10 mg/g 30142-0210-02 | Kroger | 1 tube | — | — | FDA listed | — |
| Athletes Foot 10 mg/g 36800-0049-01 | TOPCO | 1 tube | — | — | FDA listed | — |
| Athletes Foot Ultra 10 mg/g 37808-0013-02 | H | 1 tube | — | — | FDA listed | — |
| Butenafine Hydrochloride Jock Itch 10 mg/g 49035-0178-08 | Wal-Mart | 1 tube | — | — | FDA listed | — |
| Athletes Foot Ultra 10 mg/g 49035-0225-08 | Wal-Mart | 1 tube | — | — | FDA listed | — |
| Athletes Foot 10 mg/g 51672-2100-01 | Sun | 1 tube | — | — | FDA listed | — |
| Jock Itch 10 mg/gthis 51672-2101-01 | Sun | 1 tube | — | — | FDA listed | — |
| Athletes Foot 10 mg/g 69842-0986-02 | CVS | 1 tube | — | — | FDA listed | — |
| Butenafine Hydrochloride 1% 10 mg/g 69842-0989-08 | CVS | 1 tube | — | — | FDA listed | — |
| Butenafine Hydrochloride 10 mg/g 73581-0210-02 | YYBA | 1 tube | — | — | FDA listed | — |
| Butenafine Hydrochloride 10 mg/g 79481-0086-01 | MEIJER | 1 tube | — | — | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2017
On the market since
Nov 2017
📍
2026
Currently FDA-listed
9 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Sep 3, 2026
What it looks like
Color
white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII LKG8494WBH
Benzyl alcohol is a clear liquid used as a preservative and solvent in medicines. It helps prevent bacterial and fungal growth and dissolves other ingredients to create uniform liquid formulations.
-
UNII 495CTZ441V
Ceteth-23 is a synthetic emulsifier made by combining cetyl alcohol with ethylene oxide. It helps mix oil and water in liquid formulations and improves how the medicine spreads on skin or is absorbed.
-
UNII 936JST6JCN
Cetyl alcohol is a waxy, fatty substance derived from plant or animal sources. It acts as an emulsifier and thickener in medicines, helping blend oil and water components and giving products a smooth, creamy texture.
-
UNII PDC6A3C0OX
Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
-
UNII FCZ5MH785I
A waxy substance made from glycerin and stearic acid. It works as an emulsifier to help mix oil and water ingredients together, and as a thickener to give the medicine its proper texture and consistency.
-
UNII 4T6H12BN9U
Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
-
UNII 581437HWX2
A synthetic oily liquid made from propylene glycol and fatty acids. It works as an emollient and solubilizer in medicines, helping dissolve active ingredients and improve how the product spreads or absorbs.
-
UNII OJ245FE5EU
Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
-
UNII 4ELV7Z65AP
Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
-
UNII 9O3K93S3TK
Trolamine is an alkaline compound used as a pH buffer and emulsifier in medicines. It helps neutralize acids, stabilize formulations, and enable mixing of oil and water-based ingredients.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
11 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesbenzyl alcohol, cetyl alcohol, glycerin, glyceryl monostearate SE, polyoxyethylene (23), propylene glycol dicaprylate, purified water, sodium benzoate, stearic acid, trolamine, white petrolatum
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerSun Pharmaceutical Industries, Inc.
Application holderSUN PHARMA CANADA INC
FDA applicationANDA205181 (ANDA)
Labeler code51672
First marketedNov 2017
Product typeHuman Otc Drug
Portfolio890 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses cures most jock itch relieves itching, burning, cracking, and scaling which accompany this condition
⏱️ Dosage and Administration ▾
Directions adults and children 12 years and older: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying apply once a day to affected skin for 2 weeks or as directed by a doctor wash hands after each use children under 12 years: ask a doctor
⚠️ Warnings ▾
Warnings For external use only Do not use on nails or scalp in or near the mouth or the eyes for vaginal yeast infections When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water. Stop use and ask a doctor if too much irritation occurs or irritation gets worse Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📦 Storage and Handling ▾
Other information do not use if seal on tube is broken or not visible store between 20° to 25° C (68° to 77° F)
🧪 Active Ingredient ▾
Active ingredient Butenafine hydrochloride 1%
🧪 Inactive Ingredients ▾
Inactive ingredients benzyl alcohol, cetyl alcohol, glycerin, glyceryl monostearate SE, polyoxyethylene (23), propylene glycol dicaprylate, purified water, sodium benzoate, stearic acid, trolamine, white petrolatum
🎯 Purpose ▾
Purpose Antifungal
📄 Do Not Use ▾
Do not use on nails or scalp in or near the mouth or the eyes for vaginal yeast infections
📄 When Using This Product ▾
When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if too much irritation occurs or irritation gets worse
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
Questions? Call 1-866-923-4914
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL - 15 g Tube Carton Clinically Proven to Cure Most Jock Itch Butenafine Hydrochloride Cream 1% Antifungal NET WT 15 g (0.53 oz) Principal Display Panel - 15 g Tube Carton
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Jock Itch (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 33%
Female · 66%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Sun Pharmaceutical Industries, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 1 tube (51672-2101-02), 1 tube (51672-2101-08), 1 tube (51672-2101-09). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Sun Pharmaceutical Industries, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.